Brimonidine Tartrate + Placebos
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Dry Eye
Conditions
Dry Eye
Trial Timeline
Dec 3, 2018 → Feb 25, 2019
NCT ID
NCT03785340About Brimonidine Tartrate + Placebos
Brimonidine Tartrate + Placebos is a phase 3 stage product being developed by Ocugen for Dry Eye. The current trial status is completed. This product is registered under clinical trial identifier NCT03785340. Target conditions include Dry Eye.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03591874 | Phase 3 | Terminated |
| NCT03785340 | Phase 3 | Completed |
Competing Products
20 competing products in Dry Eye